跳至主要内容
临床试验/CTRI/2023/10/058797
CTRI/2023/10/058797尚未招募4 期

Efficacy of single session MET in Benzodiazepine abuse with comorbid substance use disorder. - NI

Central Institute of Psychiatry0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a. Patients who are abusing benzodiazepine (Bendep-SRQ score is equal to 2 or above) with comorbid substance use disorder as per ICD-10, Classification of Mental and Behavioural Disorders, DCR, WHO, 1993.
  • b. Age range 18 to 60 years
  • c. Male gender
  • d. Minimum level of education is 5th grade, who can read and write.
  • e. Patients who give informed consent for the study.

排除标准

  • a. Patients who have a history of significant medical or neurological and chronic physical illness.
  • b. Patients who are currently in withdrawal and delirium.
  • c. Patients who have any other mental illness apart from mild to moderate anxiety (score of less than 24 on HAM-A) and mild to moderate depression ( score of less than 18 on HAM-D)
  • d. Patients unwilling to participate for the study.

研究者

相似试验